Lateral and Amazon Capital invest in Cambridge life sciences

Investment company Lateral has acquired a key site in Cambridge for £15 mln (€17.3 mln) from an overseas investor as part of its drive to deliver lab space to the life sciences sector.

Would you like to read more? Log in first (top right of the screen) or take a trial.